Tags Archive Navigation
icon
-
Media ReleaseNovartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria
-
StorySickle cell screening urged for newborns in Africa
-
StoryHow Emily’s act of bravery inspired a wave of continued innovation
-
Media ReleaseNovartis to initiate SMART Phase 3b global study of Zolgensma in children up to 21 kg, building on real-world experience
-
Media ReleaseNovartis Cosentyx® receives EU approval for first-line systemic treatment in pediatric psoriasis
-
StoryVisionary: Silke Mader has a vision for the care of premature infants and their parents
-
StoryProtecting our tomorrows: Portraits of Meningococcal Disease
-
StoryParenting a child with a rare disease
-
StoryOne boy’s quest to battle cancer
-
StoryCreative ways to help kids understand rare diseases
-
StoryFighting respiratory disease at the source
-
StoryFighting pneumonia, the biggest killer of young children